16291601

Source:http://linkedlifedata.com/resource/pubmed/id/16291601

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0019134, umls-concept:C0019139, umls-concept:C0027051, umls-concept:C0030705, umls-concept:C0040044, umls-concept:C0205210, umls-concept:C0332293, umls-concept:C1274040
pubmed:issue	25
pubmed:dateCreated	2005-12-20
pubmed:abstractText	Low-molecular-weight heparin (LMWH) offers pharmacological and practical advantages over unfractionated heparin (UFH). Whether these advantages translate into greater infarct-related artery patency and fewer adverse clinical events in patients with ST-elevation myocardial infarction (STEMI) receiving fibrinolytic therapy remains under study.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0147763
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Aspirin, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, http://linkedlifedata.com/resource/pubmed/chemical/Heparin, Low-Molecular-Weight, http://linkedlifedata.com/resource/pubmed/chemical/Ticlopidine, http://linkedlifedata.com/resource/pubmed/chemical/clopidogrel
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1524-4539
pubmed:author	pubmed-author:AntmanElliott MEM, pubmed-author:BraunwaldEugeneE, pubmed-author:CannonChristopher PCP, pubmed-author:Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in..., pubmed-author:DellborgMikaelM, pubmed-author:GibsonC MichaelCM, pubmed-author:KeltaiMatyasM, pubmed-author:Leiva-PonsJose LJL, pubmed-author:McCabeCarolyn HCH, pubmed-author:MontalescotGillesG, pubmed-author:MorrowDavid ADA, pubmed-author:MurphySabina ASA, pubmed-author:SabatineMarc SMS
pubmed:issnType	Electronic
pubmed:day	20
pubmed:volume	112
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	3846-54
pubmed:meshHeading	pubmed-meshheading:16291601-Adolescent, pubmed-meshheading:16291601-Adult, pubmed-meshheading:16291601-Aged, pubmed-meshheading:16291601-Aspirin, pubmed-meshheading:16291601-Coronary Angiography, pubmed-meshheading:16291601-Coronary Thrombosis, pubmed-meshheading:16291601-Drug Therapy, Combination, pubmed-meshheading:16291601-Electrocardiography, pubmed-meshheading:16291601-Female, pubmed-meshheading:16291601-Fibrinolytic Agents, pubmed-meshheading:16291601-Hemorrhage, pubmed-meshheading:16291601-Heparin, pubmed-meshheading:16291601-Heparin, Low-Molecular-Weight, pubmed-meshheading:16291601-Humans, pubmed-meshheading:16291601-Male, pubmed-meshheading:16291601-Middle Aged, pubmed-meshheading:16291601-Myocardial Infarction, pubmed-meshheading:16291601-Myocardial Reperfusion, pubmed-meshheading:16291601-Recurrence, pubmed-meshheading:16291601-Ticlopidine, pubmed-meshheading:16291601-Treatment Outcome, pubmed-meshheading:16291601-Vascular Patency
pubmed:year	2005
pubmed:articleTitle	Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
pubmed:affiliation	Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. msabatine@partners.org
pubmed:publicationType	Journal Article, Randomized Controlled Trial